Senataxin controls meiotic silencing through ATR activation and chromatin remodeling by Yeo, Abrey et al.
OPEN
ARTICLE
Senataxin controls meiotic silencing through ATR
activation and chromatin remodeling
Abrey J Yeo1,2, Olivier J Becherel1,3, John E Luff1, Mark E Graham4, Derek Richard5, Martin F Lavin1,2
1The University of Queensland, UQ Centre for Clinical Research (UQCCR), Brisbane, QLD, Australia; 2School of Medicine,
The University of Queensland, Herston, Brisbane, QLD, Australia; 3School of Chemistry and Molecular Biosciences, The
University of Queensland, St Lucia, Brisbane, QLD, Australia; 4Children’s Medical Research Institute, The University of
Sydney, Westmead, NSW, Australia; 5Cancer and Ageing Research Program, Faculty of Health, Queensland University of
Technology, Brisbane, QLD, Australia
Senataxin, defective in ataxia oculomotor apraxia type 2, protects the genome by facilitating the resolution of
RNA–DNA hybrids (R-loops) and other aspects of RNA processing. Disruption of this gene in mice causes failure of
meiotic recombination and defective meiotic sex chromosome inactivation, leading to male infertility. Here we provide
evidence that the disruption of Setx leads to reduced SUMOylation and disruption of protein localization across the XY
body during meiosis. We demonstrate that senataxin and other DNA damage repair proteins, including ataxia
telangiectasia and Rad3-related protein-interacting partner, are SUMOylated, and a marked downregulation of both
ataxia telangiectasia and Rad3-related protein-interacting partner and TopBP1 leading to defective activation and
signaling through ataxia telangiectasia and Rad3-related protein occurs in the absence of senataxin. Furthermore,
chromodomain helicase DNA-binding protein 4, a component of the nucleosome remodeling and deacetylase chromatin
remodeler that interacts with both ataxia telangiectasia and Rad3-related protein and senataxin was not recruited
efﬁciently to the XY body, triggering altered histone acetylation and chromatin conformation in Setx−/− pachytene-staged
spermatocytes. These results demonstrate that senataxin has a critical role in ataxia telangiectasia and Rad3-related
protein- and chromodomain helicase DNA-binding protein 4-mediated transcriptional silencing and chromatin remodeling
during meiosis providing greater insight into its critical role in gene regulation to protect against neurodegeneration.
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Introduction
Mutations in senataxin give rise to the autosomal
recessive cerebellar disorder, ataxia oculomotor
apraxia type 2 (AOA2) [1, 2], and also to autosomal
dominant juvenile-onset, amyotrophic lateral sclerosis
4 [3, 4]. It is still unclear how mutations in the Setx
gene, located in close proximity, give rise to dominant
and recessive disorders. However, there is evidence that
posttranslational modiﬁcations of senataxin may help
explain involvement in these different disease forms [5].
Senataxin is homologous to the yeast RNA–DNA
helicase, Sen1, a component of the Nrd1 complex,
involved in RNA polymerase II transcription
termination and processing of noncoding nucleolar
RNAs [6–8]. Similar to that reported for other proteins
mutated in cerebellar ataxias, senataxin appears to
have a role in protecting the genome against DNA
damage [9–11]. Greater insight into its role in the
response to DNA damage has been provided in recent
studies. This protein was reported to interact with
proteins involved in transcription and was shown to
have a role in transcription termination, mRNA
splicing efﬁciency and splice site selection [12]. Insight
into its role in transcriptional termination was provided
by the observation that senataxin resolves RNA–DNA
hybrids (R-loops) and as a consequence allows Xrn2
(5′43′ exonuclease) access at the 3′ cleavage poly (A)
site, nascent transcript degradation and consequently
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polymerase II release and termination [13]. In yeast,
Sen1 has also been shown to protect the genome from
R-loop-mediated DNA damage [14]. The continuing
presence of R-loops can have a negative impact on
transcription elongation, leading to collisions with
DNA replication forks and/or compromising genomic
integrity by being a source of hypermutation or causing
hyper-recombination [15]. More recently, senataxin
has been localized to sites of collision between
components of the replisome and the transcriptional
apparatus [16]. By recognizing and resolving R-loops,
it has an important role at the interface of transcription
and the DNA damage response [16]. Evidence for this
also exists in yeast where Sen1 has a key role in
coordinating replication and transcription [17].
Senataxin has also been shown to suppress the
anti-viral transcriptional response to control viral
biogenesis [18]. It appears to do so by negatively
regulating IRF3-dependent expression and promoting
early termination of RNA polymerase II. At present, it
remains unclear as to whether R-loops are responsible
for the neurodegenerative changes that characterize
AOA2. We previously reported the accumulation of
R-loops in proliferating cells of Setx mutant mice
treated with the topoisomerase inhibitor, topotecan
hydrochloride, but failed to detect any R-loops in the
brains of mice treated with the same agent [19].
Disruption of the Setx gene in mice failed to reveal
any signiﬁcant neurological abnormalities or any
evidence of neurodegeneration [20]. However, male
mutant mice were infertile and there was evidence of
reduced fertility in females. Male germ cells proceeded
normally from spermatogonia up to the pachytene
stage of meiosis in Setx−/−, but failed to form mature
spermatids [20]. Successful generation of programmed
DNA double-strand breaks (DSB) and the initiation of
DNA repair was observed in Setx−/− spermatocytes,
but RAD51 foci were abnormally retained in the
pachytene stage and DNA DSBs persisted, revealing a
defect in homologous recombination. In addition,
absence of Mlh1 foci in Setx−/− spermatocytes provided
further evidence of failure to complete recombination.
Setx−/− spermatocytes also showed an accumulation of
R-loops and underwent apoptosis. Furthermore,
senataxin localized to the XY chromosomes at the
pachytene stage and abnormal diffusion of DNA
damage rep (DDR) proteins into the XY chromatin
domain was observed, predicting that the XY chro-
mosomes would fail to be transcriptionally silenced in
Setx−/− pachytene cells, which turned out to be the case
[20]. These results pointed to a key role for senataxin in
both meiotic homologous recombination and in
meiotic sex chromosome inactivation (MSCI).
In this study, we used the Setx mutant mouse
model to investigate the role of senataxin in meiotic
transcriptional silencing. Loss of senataxin caused a
marked decrease in protein SUMOylation across the
XY body during the pachytene stage of meiosis.
Senataxin itself was SUMOylated as well as several
other proteins that include the ataxia telangiectasia
and Rad3-related protein (ATR)-interacting partner,
ATRIP, and in its absence, there was a marked
downregulation and mislocalization of both ATRIP
and TopBP1. Downregulation of ATRIP resulted from
the failure of NIMA (never in mitosis gene a)-related
kinase 1 (NEK1) to localize to the XY body and
this led to defective ATR signaling. Chromodomain
helicase DNA-binding protein 4 (CHD4), a key com-
ponent of the nucleosome remodeling and deacetylase
(NuRD) histone deacetylase chromatin remodeling
complex, which interacts with both ATR and sena-
taxin, was not efﬁciently recruited to the XY body,
leading to persistent histone acetylation of the XY
chromosomes and altered chromatin structure in
Setx−/− spermatocytes. These data provide further
evidence of a critical role for senataxin in transcrip-
tional silencing.
Results
Senataxin is SUMOylated on the XY body
The various stages of meiosis can be differentiated
by immunostaining for synaptonemal complex protein
3 (SCP3), a proteinaceous component of the axial
element of the synaptonemal complex required for
chromosomal synapsis [21]. We have previously shown
that senataxin localized as a diffuse ‘cloud’ to the XY
chromosomes in spermatocytes at the pachytene stage
of male meiosis where it has an essential but undeﬁned
role in MSCI [20] (Figure 1a). Small ubiquitin-like
modiﬁer (SUMO) proteins have also been localized to
the XY chromosomes and they have been implicated in
the initiation of MSCI [20]. A yeast two-hydrid screen
to detect SUMO-1- and SUMO-2/3-interacting motifs
previously identiﬁed proteins involved in DNA repair
and transcriptional repression [22]. and growing
evidence implicated SUMO as an important post-
translational modiﬁcation to modulate protein
assemblies, activity and function [23]. Therefore, we
investigated whether senataxin might be SUMOylated
as part of its role in MSCI. Immunostaining for
SUMO-1 of spermatocyte spreads revealed an intense,
diffuse pattern of staining across the XY body in
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Setx+/+ spermatocytes (Figure 1b). On the other hand,
when senataxin was disrupted, staining for SUMO-1
was signiﬁcantly reduced and was conﬁned to the
unsynapsed region of the axial element of the XY
chromosomes. A similar pattern of staining was
observed with SUMO-2/3 (Supplementary Figure S1A).
The early appearance of SUMO-1, which precedes the
accumulation of γH2AX on the XY chromosomes, and
the lack of SUMO-2/3 detection in zygotene sperma-
tocytes, suggested a more speciﬁc role for SUMO-1
in the initiation of XY inactivation [24]. Therefore,
SUMO-1 was chosen for further investigation. A
bioinformatics tool, GPS-SUMO (http: //sumosp.bio-
cuckoo.org), which predicts sites of SUMOylation and
SUMO-interacting motifs based on consensus
sequence predicted three sites of SUMOylation
(Figure 1c) and three SUMO-interacting motifs in
senataxin (Supplementary Figure S1B). All three
potential SUMOylation sites are located in the N
terminus of senataxin. Consistent with this prediction,
Hecker et al. [22] previously identiﬁed senataxin as a
SUMO-1/2-interacting protein using a yeast two-
hybrid approach, and more recently an interaction
between senataxin and Rrp45, a subunit of the exo-
some, was found to be dependent on the SUMOylation
of senataxin [5]. Co-immunoprecipitation of senataxin
and SUMO-1 was detected in cell extracts made from
Setx+/+ testes, and as expected, no signal was detected
in Setx−/− extracts (Figure 1d). This was conﬁrmed
Figure 1 Senataxin is SUMOylated at the XY chromosomes in
spermatocytes. (a) Immunostaining for senataxin revealed its
localization to the XY chromosomes as a diffuse cloud during
the pachytene stage in spermatocytes of Setx+/+ mice. Some
background staining was also observed on the autosomes.
As expected, no senataxin was detected in Setx−/− spermatocytes.
(b) Immunostaining for SUMO-1 in Setx+/+ and Setx−/− spermato-
cytes revealed a diffuse staining over the XY chromosomes in
Setx+/+ spermatocytes. In contrast, staining was largely restricted
to the axes of the XY chromosomes in Setx−/− spermatocytes.
(c) GPS-SUMO, a bioinformatics tool, predicted three potential
SUMOylation sites for senataxin. (d) Endogenous senataxin
and SUMO-1 were co-immunoprecipitated and immunoblotted
separately, showing SUMOylation of senataxin in Setx+/+
spermatocytes. A negative control for the immunoprecipitation
(IP) using nonspeciﬁc (NS) immunoglobulin G (IgG) was
also performed. As expected, input lanes show the presence
of senataxin in Setx+/+ but not in Setx−/− total cell extracts.
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was
used as a loading control. (e) Through a proximity ligation assay
(PLA), an interaction between senataxin and SUMO-1 was
observed over the XY chromosomes as a concentration of red
foci (middle panel). Some more scattered red foci were also
observed over the autosomes. A negative control without a
primary antibody (left panel) as well as a positive control (right
panel) using antibodies against breast cancer type 1 susceptibility
protein (BRCA1) and ataxia telangiectasia and Rad3-related
protein (ATR), two proteins known to interact directly, was
performed alongside. Scale bar, 20 μm. Synaptonemal complex
protein 3 (SCP3), which indicates the axial elements of the
synaptonemal complex. Dotted circle, XY chromosomes.
Abrey J Yeo et al
3
Cell Discovery | www.nature.com/celldisc
Figure 2 Ataxia telangiectasia and Rad3-related protein-interacting partner (ATRIP) protein levels are reduced in the absence of
senataxin. (a) Liquid chromatography mass spectrometry (LC-MS/MS) on immunoprecipitation (IP) from Setx+/+ and Setx−/−
mouse testes using anti-SUMO-1 antibody revealed ATRIP as a candidate SUMOylated protein in Setx+/+ but not in Setx−/−
spermatocytes. Protein identiﬁcation was visualized on the Scaffold Q+S application (Proteome Software, Portland, OR, USA).
(b) IP from Setx+/+ and Setx−/− testes extracts for SUMO-1 and immunoblotting for ATRIP conﬁrmed the SUMOylation of ATRIP.
A negative control for the IP using nonspeciﬁc (NS) immunoglobulin G (IgG) was also performed. Input lanes show the presence
of ATRIP in Setx+/+ but not in Setx−/− total cell extracts. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a
loading control. (c) Immunostaining for ATRIP revealed a strong signal on the axial element of the XY chromosomes in Setx+/+
spermatocytes. On the other hand, decreased staining intensity for ATRIP was observed in Setx−/− spermatocytes. Scale bar,
20 μm. SCP3, Synaptonemal complex protein 3. Dotted circle, XY chromosomes. (d) Quantitation of ATRIP ﬂuorescence
intensity staining (shown as fold change) in Setx+/+ and Setx−/−. Data are plotted as the mean± s.d. Statistical analysis was
performed using the Student’s t-test, *Po0.05. Number of animals, n = 3.
Senataxin facilitates meiotic gene silencing
4
Cell Discovery | www.nature.com/celldisc
by the immunoprecipitation with an anti-SUMO-1
antibody (Figure 1d). Although immunoprecipitation
conﬁrmed the SUMOylation of senataxin, a proximity
ligation assay (PLA) for both senataxin and SUMO-1
on Setx+/+ spermatocyte spreads was performed to
determine the localization of the senataxin/SUMO-1
interaction at the pachytene stage. PLA allows the
visualization of in situ endogenous protein–protein
interactions by the appearance of ﬂuorescent spots
because of ampliﬁcation and subsequent incorporation
of ﬂuorescent nucleotides on complementary strands
that are conjugated to target antibodies [21]. The
results provided further evidence that senataxin and
SUMO-1 interacted with one another primarily on the
XY chromosomes, as evidenced by the majority of the
positive signals (red dots) focused over the XY body
(Figure 1e). These results demonstrate that senataxin is
SUMOylated and that it localizes primarily to the XY
chromosomes.
Defective SUMOylation of XY chromosome proteins in
Setx−/− pachytene cells
Given that the SUMOylation signal intensity was
markedly decreased over the XY body and was mis-
localized in the absence of senataxin, we predicted that
other proteins localized to the XY body would depend
on senataxin for their SUMOylation. To identify these
SUMOylated proteins, we used immunoprecipitation
with an anti-SUMO-1 antibody with extracts
from Setx+/+ and Setx−/− testes followed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE), and identiﬁcation of Coomassie-stained
bands by liquid chromatography mass spectrometry
(LC-MS/MS). A stringent threshold for protein
identiﬁcation was set at Po0.01, the false discovery
rate was set at 0.01% and a minimum of two unique
peptides was used as an arbitrary threshold for
conﬁdent protein identiﬁcation. Several proteins were
identiﬁed (Supplementary Table S1), which included
several candidates related or potentially related to
defective SUMOylation.
Among the SUMOylated proteins or those bound
to SUMOylated proteins were those involved in
chromatin remodeling (ATRX and RUVB2), in tran-
scription regulation (DHX15 and YBOX3) and the
regulatory partner of ATR, ATRIP, consistent with a
role for SUMOylation in the DNA damage response
and transcription. Data for ATRIP identiﬁcation
are presented in Figure 2a. We conﬁrmed the
SUMOylation of ATRIP in spermatocytes by carrying
out immunoprecipitation with anti-SUMO-1 antibody
and immunoblotting with anti-ATRIP antibody
(Figure 2b). A reduction in ATRIP SUMOylation was
observed in Setx−/− spermatocytes as compared with
Setx+/+, suggesting a lower level of ATRIP in Setx−/−.
Indeed, this is in agreement with the difﬁculty of
detecting endogenous levels of ATRIP in total cell
extracts from Setx−/− (Figure 2b). Furthermore, the
decrease in ATRIP protein levels observed in Setx−/−
testes was not a defect in the expression of ATRIP
(Supplementary Figure S3B), suggesting that senataxin
does not directly affect the transcriptional regulation of
ATRIP.
The reduction of ATRIP, and consequently
SUMOylated ATRIP, in Setx−/− spermatocytes and the
importance of ATRIP in maintaining the stability
and activity of ATR prompted us to investigate the
localization of ATRIP in spermatocytes from these
mice. A strong signal for ATRIP that was restricted
largely to the axial element of the XY chromosomes
was observed in Setx+/+ pachytene spermatocytes
(Figure 2c). Additionally, some background staining
for ATRIP was observed on the autosomes. Although
the localization of ATRIP in Setx−/− spermatocytes was
similar to that observed in Setx+/+ spermatocytes, the
signal was markedly reduced. Thus, a reduction in
ATRIP protein levels and/or defective recruitment to
the XY chromosomes appears to occur in Setx−/−
pachytene-staged spermatocytes. Quantitation of
ATRIP ﬂuorescence intensity staining on the XY
chromosomes revealed an ~ 3.3-fold reduction in
Setx−/− compared with Setx+/+ (Figure 2d).
Activation of ATR and downstream signaling is
defective in Setx−/− spermatocytes
ATR has also been shown to have a key role in
MSCI where it is required for the phosphorylation of
H2AX [25]. Brieﬂy, ATR is a kinase that is activated
upon recognition of DNA damage, which includes
single-stranded DNA breaks [26]. Single-stranded
DNA is ﬁrst detected and coated by replication
protein A (RPA), and subsequently the ATR-ATRIP
complex is recruited to sites of DNA damage and
activated by TopBP1, leading to the activation/
phosphorylation of its downstream substrates, which
include RPA and checkpoint kinase 1 (CHK1)
(Figure 3a) [27, 28]. The initiation of MSCI begins with
the recruitment of breast cancer type 1 susceptibility
protein (BRCA1) to the axes of the XY chromosomes,
which then promotes ATR recruitment [25]. As shown
in Supplementary Figure S2, normal recruitment of
BRCA1 was observed in both Setx+/+ and Setx−/− mice,
indicating that the initiation of MSCI occurs typically
in these mice. This then suggested that the defect in
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Figure 3 Ataxia telangiectasia and Rad3-related protein (ATR) activity and signaling is defective in the absence of senataxin.
(a) A schematic illustration of the ATR signaling pathway and the proteins investigated. (b) TopBP1 was observed to localize
predominantly to the axial element of the XY chromosomes in Setx+/+ spermatocytes. In contrast, decreased staining intensity for
TopBP1 was observed in Setx−/− spermatocytes. Quantitation of TopBP1 ﬂuorescence intensity staining (shown as fold change)
in Setx+/+ and Setx−/−. (c) ATR localized as a cloud in Setx+/+ spermatocytes, whereas in Setx−/−, ATR was conﬁned to the axial
element of the XY chromosomes. Quantitation of ATR ﬂuorescence intensity staining (shown as fold change) in Setx+/+ and
Setx−/−. (d) Immunostaining for phospho-S428 ATR (p-ATR(S428) showed a cloud over the XY chromosomes in Setx+/+
spermatocytes as expected, whereas phospho-S428 ATR (p-ATR) was retained on the axial element of the XY chromosomes
in Setx−/− spermatocytes. Quantitation of p-ATR ﬂuorescence intensity staining (shown as fold change) in Setx+/+ and Setx−/−.
(e) Immunostaining for p-RPA(S33) showed a diffuse staining pattern over the XY body in Setx+/+ spermatocytes as expected,
whereas it was largely retained on the axial element of the XY chromosomes in Setx−/− spermatocytes. Quantitation of p-RPA
ﬂuorescence intensity staining (shown as fold change) in Setx+/+ and Setx−/−. (f) Localization of phospho-S317 CHK1(S317)
(p-CHK1(S317)) to XY chromatin in Setx+/+. Reduced levels of p-CHK1(S317) localized mainly to the axial element of the XY
chromosomes in Setx−/− spermatocytes. Quantitation of p-CHK1 ﬂuorescence intensity staining (shown as fold change) in Setx+/+
and Setx−/−. Scale bar, 20 μm. Synaptonemal complex protein 3 (SCP3). Dotted circle, XY chromosomes. All data were plotted as
the mean± s.d. Statistical analysis was performed using the Student’s t-test, *Po0.05. Number of animals, n = 3.
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MSCI in Setx−/− spermatocytes lies downstream of this
initial step. As TopBP1 acts as a general activator of
ATR [22] and this activation is mediated through
ATRIP, we predicted that there might also be a defect
in ATR activation and downstream signaling in Setx−/−
spermatocytes. Immunostaining on spermatocytes
of Setx mice showed that TopBP1 localized pre-
dominantly on the axial elements of the XY chromo-
somes in Setx+/+ spermatocytes as expected, whereas a
much fainter signal was observed in Setx−/− spermato-
cytes, despite a similar localization to that observed in
Setx+/+ (Figure 3b). Quantitation of ﬂuorescence
intensity of TopBP1 also showed an ~ 2.6-fold reduc-
tion in Setx−/− as compared with Setx+/+ (Figure 3b).
These results suggested a potential defect at the level
of ATR function and downstream signaling in the
absence of senataxin. In addition to coordinating
DDR, ATR is required for the phosphorylation of
histone H2AX on the XY chromosomes during MSCI
[25]. Although the exact purpose of this phosphoryla-
tion remains unclear, it has been hypothesized that it is
necessary for initiating chromatin condensation and
repression of transcription [29]. We observed that ATR
formed a diffuse cloud over the XY body in Setx+/+
spermatocytes as reported previously [30], whereas it
was localized largely on the axial element of the XY
chromosomes in Setx−/− spermatocytes, failing to dif-
fuse out into XY chromatin (Figure 3c). Quantitation
of ﬂuorescence intensity of ATR also showed an
~ 2-fold reduction in Setx−/− as compared with Setx+/+
(Figure 3c). To determine whether the altered locali-
zation of ATR might reﬂect a difference in its activity,
immunostaining against an active form of ATR,
phospho-S428 ATR (p-ATR) was performed. Results
showed a similar staining pattern to that observed for
ATR, with staining being conﬁned to the unsynapsed
region of the axial elements of the XY chromosomes
(Figure 3d). Quantitation of ﬂuorescence intensity of
p-ATR also showed an ~ 2.4-fold reduction in Setx−/−
as compared with Setx+/+ (Figure 3d). These data point
to a defect in the diffusion of p-ATR, which could lead
to alterations in the downstream DDR signaling that
occurs during MSCI. To examine this possibility, we
next investigated ATR signaling in the absence of
senataxin by immunostaining for two ATR substrates,
RPA and CHK1 [31, 32]. Phospho-S33 RPA (p-RPA)
was observed to form an intense diffuse cloud over
the XY chromosomes in Setx+/+ spermatocytes,
whereas p-RPA was signiﬁcantly reduced in intensity
and localized mainly on the axial element of the XY
chromosomes in Setx−/− spermatocytes (Figure 3e).
Quantitation of ﬂuorescence intensity of p-RPA also
showed an ~ 2.2-fold reduction in Setx−/− as compared
with Setx+/+ (Figure 3e). CHK1, a kinase required for
cell cycle checkpoint activation and a well-documented
downstream target of ATR for phosphorylation
[33, 34], was next assessed. The ATR-phosphorylated
form of CHK1 phospho-S317 CHK1 (p-CHK1)
formed a diffuse cloud over the XY chromosomes in
Setx+/+ spermatocytes, whereas a reduced signal that
was largely retained on the axial element was observed
in Setx−/− spermatocytes (Figure 3f). Quantitation
of ﬂuorescence intensity of p-CHK1 also showed an
~ 3.8-fold reduction in Setx−/− as compared with Setx+/+
(Figure 3f). Both p-RPA and p-CHK1 exhibited
similar staining patterns as those of ATR and p-ATR
in Setx+/+ and Setx−/− spermatocytes. Immunoblotting
was carried to determine the levels of the proteins
involved in ATR signaling. Both ATRIP and TopBP1
protein levels were markedly reduced in Setx−/−,
in agreement with the immunoﬂuorescence data
(Supplementary Figure S3A). However, similar levels
of TopBP1 and ATRIP mRNAs were observed
between Setx+/+ and Setx−/−, suggesting that senataxin
does not directly regulate the expression of these genes
at the transcriptional level (Supplementary Figure
S3B). Although ATR and CHK1 were present in
normal levels, there was evidence that ATR activation
was lower in Setx−/− as observed with decreased p-ATR
protein levels (Supplementary Figure S3A). Taken
together, these data support a defect in ATR activity
and downstream signaling in Setx−/− as this activity is
conﬁned to the axial elements of the XY chromosomes,
which could account for the failure of MSCI in
these mice.
A recent report showed that the kinase activity
of NEK1 is critical for initiating the ATR response
following DNA damage [35]. Cells lacking NEK1
failed to support ATR autophosphorylation, did not
efﬁciently phosphorylate ATR downstream substrates
and exhibited signiﬁcantly reduced levels of ATRIP
[35]. Thus, it is possible that in Setx−/− cells, a defect in
NEK1 may be present, which could in turn account
for the defect in ATR activity observed here, and
consequently a failure in MSCI. Immunoblotting for
NEK1 protein from total cell extracts from testes of
Setx+/+ and Setx−/− mice revealed an ~ 1.7 fold decrease
in NEK1 in Setx−/− (Figure 4a), despite similar
gene expression levels (Supplementary Figure S3B).
Immunostaining showed that NEK1 localized to the
axial element of the autosomes, with a stronger signal
on the XY chromosomes in Setx+/+ spermatocytes
(Figure 4b). In contrast, NEK1 localized neither to
the autosomes nor the XY chromosomes in Setx−/−
Abrey J Yeo et al
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spermatocytes, but rather formed a diffuse staining
pattern throughout the nucleus. Quantitation of
ﬂuorescence intensity of NEK1 also showed an
~ 3.6-fold reduction in Setx−/− as compared with Setx+/+
(Figure 4b). The decreased protein level of NEK1 as
well as its mislocalization in Setx−/− spermatocytes
suggests that senataxin may modulate the expression
indirectly and/or localization of NEK1, and that
NEK1 disruption may in turn account for the desta-
bilization of ATRIP and the defect in ATR signaling
observed in Setx−/− spermatocytes.
Lack of CHD4 recruitment to the XY body in the
absence of senataxin
We have previously shown that in the absence of
senataxin, failure of MSCI is associated with differ-
ential chromatin conformation as observed by defec-
tive ubiquitination of histone H2A [20]. The abnormal
ATR activation and signaling observed in Setx−/−
spermatocytes and the alterations in X- and Y-linked
gene expression in Setx−/− spermatocytes observed
previously [20] could also result from defective
chromatin remodeling. Relevant to this, the CHD4,
a member of the NuRD complex [36], was shown
previously to interact with senataxin in HeLa cells [16].
Gene expression connectivity mapping provided
additional evidence that senataxin and CHD4 are
interacting partners (Figure 5a). Connectivity mapping
is an advanced bioinformatics technique that is used to
establish the connections among different biological
states via their expression proﬁles/signatures [37].
In addition to identifying CHD4 as a senataxin-
interacting protein, other proteins implicated in
transcription control were also identiﬁed (Figure 5a).
CHD4 has also been reported to interact with ATR
[38], suggesting a link between its role in mediating
checkpoints induced by DNA damage and chromatin
remodeling by deacetylation [39]. Immunostaining for
CHD4 revealed a similar pattern of localization to the
XY chromosomes in Setx+/+ and Setx−/− spermatocytes
(Figure 5b). Quantitation of CHD4 ﬂuorescence
intensity staining on the XY chromosomes revealed an
~ 5-fold reduction in Setx−/− compared with Setx+/+
(Figure 5c). This was not explained by reduced protein,
Figure 4 NNIMA (never in mitosis gene a)-related kinase 1 (NEK1) localization and protein levels are disrupted in the absence of
senataxin. (a) Immunoblotting from testes extracts revealed a decrease in NEK1 protein levels in Setx−/− as compared with Setx+/+
spermatocytes. α-Tubulin was used as a loading control. Quantitation of NEK1 band intensity staining (shown as fold change) in
Setx+/+ and Setx−/−. (b) NEK1 was observed to localize speciﬁcally to the axial element of the autosomes with a stronger intensity
on the XY chromosomes in Setx+/+ spermatocytes, whereas NEK1 in Setx−/− spermatocytes was not associated with the XY
chromosomes but was scattered throughout the nucleus. Quantitation of NEK1 ﬂuorescence intensity staining (shown as fold
change) in Setx+/+ and Setx−/−. Scale bar, 20 μm. Dotted circle, XY chromosomes. All data were plotted as the mean± s.d.
Statistical analysis was performed using the Student’s t-test, *Po0.05. Number of animals, n = 3.
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as similar levels of CHD4 protein were observed in
both Setx+/+ and Setx−/− testes extracts (Figure 5d),
indicating that the faint CHD4 staining in Setx−/−
spermatocytes most likely resulted from a defect in
its recruitment to the XY chromosomes. Although
CHD4 was shown to interact with senataxin by
co-immunoprecipitation [16] and predicted from con-
nectivity mapping in somatic cells, it was important to
determine whether senataxin and CHD4 interacted
in vivo in spermatocytes. Immunostaining for senataxin
and CHD4 revealed colocalization on the XY
chromosomes (Figure 5e). Using PLA, we revealed an
in situ interaction between senataxin and CHD4 at the
XY chromosomes in Setx+/+ spermatocytes (Figure 5f),
thus providing further evidence for the in vivo
interaction between these two proteins. This suggests
that senataxin and ATR are involved in the recruit-
ment of CHD4 to the XY body where they function
together in chromatin remodeling required for XY
silencing.
Figure 5 Senataxin interacts with and affects chromodomain helicase binding DNA protein 4 (CHD4) localization. (a) Pathway
analysis of the senataxin connectivity map was performed using data from PCViz Pathway Commons Network Visualizer (http://
www.pathwaycommons.org); this demonstrated that senataxin was coregulated with three ubiquitin ligases and an ubiquitin
peptidase, along with two other helicases. (b) Immunostaining for CHD4 revealed a strong signal on the XY chromosomes in
Setx+/+ spermatocytes, whereas decreased levels of CHD4 were observed in Setx−/− spermatocytes. (c) Quantitation of CHD4
ﬂuorescence intensity staining (shown as fold change) in Setx+/+ and Setx−/−. All data were plotted as the mean± s.d. Statistical
analysis was performed using the Student’s t-test, *Po0.05. Number of animals, n = 3. (d) Immunoblotting from testes extracts
for CHD4 revealed similar levels of this protein in both Setx−/− and Setx+/+ mice. (e) Co-immunoﬂuorescence of senataxin and
CHD4 revealed overlapping staining over the XY domain in Setx+/+ spermatocytes. (f) Proximity ligation assay (PLA) between
senataxin and CHD4 revealed an interaction between these proteins at the XY chromosomes in spermatocytes of Setx+/+ mice
(middle panel). A negative control without primary antibody (left panel) as well as a positive control (right panel) using antibodies
against breast cancer type 1 susceptibility protein (BRCA1) and ATR, two proteins known to interact directly, was performed
alongside. Scale bar, 20 μm. Dotted circle, XY chromosomes.
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Persistence of histone acetylation on the XY
chromosomes in Setx−/− spermatocytes
CHD4 functions as part of the NuRD complex to
control the programming of cell states during devel-
opment, triggering chromatin conformation changes
by posttranslational modiﬁcations, and consequently
changes in transcriptional activity [38–40]. This com-
plex is capable of both opening and closing chromatin,
with a recent report demonstrating that CHD4 is the
most frequent participant in chromatin closing events
[41]. A defect in the recruitment of CHD4 to the XY
body is predicted to result in more open chromatin,
compatible with the presence of active RNA poly-
merase II transcription and MSCI failure in Setx−/−
spermatocytes [20]. To address this further, we deter-
mined the status of histone posttranslational mod-
iﬁcations such as histone H3 acetyl K9 (H3K9Ac), a
histone modiﬁcation associated with transcription [42].
As expected, this modiﬁcation was only observed on
the autosomes and not on the XY chromosomes in
Setx+/+ pachytene-staged spermatocytes, consistent
with the onset of MSCI, whereas H3K9Ac strongly lit
up the XY chromosomes in Setx−/− spermatocytes
(Figure 6a). Quantitation of H3K9Ac ﬂuorescence
intensity staining on the XY chromosomes revealed an
~ 17-fold increase in Setx−/− compared with Setx+/+
(Figure 6b). Further evidence of open chromatin on the
XY chromosomes was provided by analyzing the
spread of histone H4 at lysine 16 (H4K16Ac), another
histone modiﬁcation associated with transcriptionally
active chromatin [42]. Similarly, H4K16Ac signal was
not on the XY chromosomes of Setx+/+ spermatocytes,
whereas a strong signal was observed on the XY
chromosomes of Setx−/− spermatocytes with additional
background signals observed on the autosomes
(Figure 6c). Quantitation of H4K16Ac ﬂuorescence
intensity staining on the XY chromosomes revealed an
~ 5-fold increase in Setx−/− compared with Setx+/+
(Figure 6d). Contrary to acetylation, histone methyla-
tion is an indicator of transcriptional repression [42].
To conﬁrm the major difference in chromatin con-
formation in Setx−/− spermatocytes, H3K4me1, an
epigenetic marker associated with transcription
repression [42], was also examined. Immunostaining
against this marker revealed a strong signal over
the XY chromosomes in Setx+/+ spermatocytes, con-
sistent with transcriptional repression and silencing
(Figure 6e). In contrast, signal for H3K4me1 was not
observed on the XY chromosomes of Setx−/− sperma-
tocytes but enhanced signals for this marker was
observed on the autosomes, suggesting a more general
genome-wide defect in chromatin topology in Setx−/−
mice (Figure 6e). Quantitation of H3K4me1 ﬂuores-
cence intensity staining on the XY chromosomes
revealed an ~ 2.5-fold reduction in Setx−/− compared
with Setx+/ +(Figure 6f). Altogether, the pattern
of histone acetylation and methylation points to
abnormalities in chromatin conformation leading to
gene activation on the XY body, which is consistent
with the MSCI failure previously observed in Setx−/−
pachytene-staged spermatocytes.
Concerted action of senataxin and CHD4 in regulating
XY silencing
Based on the localization and in situ interaction of
senataxin and CHD4 on the XY chromosomes and the
aberrant histone acetylation marks observed in Setx−/−
pachytene spermatocytes, we decided to investigate the
relationship between R-loop formation, senataxin and
CHD4 in modulating XY silencing. GC skew is a
common characteristic of human CpG islands and
R-loops have been shown to interfere with CpG island
methylation at promoter sites, which can then lead to
silencing defects [43]. To gain further mechanistic
insight into MSCI, we ﬁrst determined whether R-loop
formation may modulate the expression of XY genes
by using microarray analysis, and subsequently carry-
ing out in silico analysis for R-loops formation sites
(RLFS) on aberrantly expressed XY genes in Setx−/−.
The mouse Timp1 gene, which displayed increased
expression in Setx−/− (Figure 7a), was found to contain
a predicted RLFS upstream of its 5'-untranslated
region (UTR) (Figure 7b). We next performed
DNA:RNA immunoprecipitation (DRIP) using the
S9.6 antibody, an antibody speciﬁc for R-loops
(Supplementary Figure S4), to conﬁrm the presence of
these structures at this locus. As shown in Figure 7c, a
higher level of R-loops (~2-fold increase) was observed
at the Timp1 locus in Setx−/− as compared with Setx+/+.
Chromatin immunoprecipitation (ChIP) with sena-
taxin also revealed its binding to this locus in Setx+/+.
As expected, only background levels of binding were
observed in Setx−/− (Figure 7c). These data are in
agreement with the role of senataxin in resolving
R-loops [13]. Interestingly, the 5′-UTR region of
Timp1 has been found to be methylated in germ cells
under normal conditions (Supplementary Figure S5),
suggesting that the absence of senataxin may lead to an
increase in R-loop formation at this locus, which
may prevent the methylation of this GC-rich region in
Setx−/−.
Gene regulation is primarily modulated by histone
methylation and/or acetylation [44, 45]. Given the
in situ interaction between senataxin and CHD4 on the
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Figure 6 Differential XY chromatin topology contributes to the failure of meiotic sex chromosome inactivation (MSCI) in Setx−/−
spermatocytes. (a) Immunostaining for the epigenetic marker of acetylation, histone H3 acetyl K9 (H3K9Ac), revealed
hyperacetylation of the XY chromosomes only in Setx−/− spermatocytes. No signals for these histone modiﬁcations were
observed over the XY domain of Setx+/+ spermatocytes as expected. (b) Quantitation of H3K9Ac ﬂuorescence intensity staining
(shown as fold change) in Setx+/+ and Setx−/−. (c) Histone H4 at lysine 16 (H4K16Ac) staining revealed similar hyperacetylation of
the XY chromosomes only in Setx−/− spermatocytes. (d) Quantitation of H4K16Ac ﬂuorescence intensity staining (shown as fold
change) in Setx+/+ and Setx−/−. (e) Immunostaining for the histone methylation mark, H3K4me1, revealed speciﬁc staining over the
XY chromosomes in Setx+/+, compatible with transcriptional silencing, but not in Setx−/− spermatocytes. (f) Quantitation of
H3K4me1 ﬂuorescence intensity staining (shown as fold change) in Setx+/+ and Setx−/−. Scale bar, 20 μm. Dotted circle, XY
chromosomes. All data were plotted as the mean± s.d. Statistical analysis was performed using the Student’s t-test, *Po0.05.
Number of animals, n = 3.
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XY chromosomes, and that CHD4 is a core compo-
nent of the histone deacetylase NuRD complex [46], we
next performed ChIP to investigate the recruitment of
CHD4 to the Timp1 locus and the histone acetylation
status of this region. As shown in Figure 7c, CHD4
bound to this region to a similar extent as senataxin in
Setx+/+, whereas an ~ 50% reduction in CHD4 binding
was observed in Setx−/−. Additionally, reduced CHD4
binding to this locus was inversely correlated with a
twofold increase in histone H3 Lys9 (H3K9) acetyla-
tion, which is in agreement with previous work
demonstrating a role for CHD4 in modulating the
modiﬁcation of this site [46].
Altogether, these data indicate that (i) R-loops form
at the 5'-UTR region of the Timp1 locus under normal
conditions, (ii) R-loops accumulate to a greater extent
at this site in the absence of senataxin and (iii) the lack
of senataxin hinders the recruitment of CHD4, which
correlates with higher levels of histone acetylation
at this locus and consequently increased Timp1
expression. Thus, we propose a mechanism in which
under normal conditions, the concomitant binding
of senataxin and CHD4 to Timp1 5'-UTR leads to
the silencing of Timp1 through the resolution of
R-loops and the deacetylation of H3K9 by the CHD4
(Figure 7d). In contrast, R-loops accumulate at the
Figure 7 Coordinated action of senataxin and chromodomain helicase DNA-binding protein 4 (CHD4) in meiotic silencing.
(a) Increased levels of expression of Timp1 in Setx−/− germ cells. (b) Diagram depicting the Timp1 gene structure, the predicted
R-loop forming site (RLFS; black bars) located upstream and in the 5′-untranslated region (5′-UTR) region of this gene and the
corresponding polymerase chain reaction (PCR) product (red bar) used in chromatin immunoprecipitation (ChIP) assays.
(c) DNA:RNA immunoprecipitation (DRIP), SETX, CHD4 and histone H3 Lys 9Ac (H3K9Ac) ChIP in Setx+/+ and Setx−/− germ cells
revealed the accumulation of R-loops, the reduced binding of CHD4 and the increased of histone H3 Lys9 (H3K9) acetylation in
Setx−/− cells. Similar levels of senataxin and CHD4 binding was observed in Setx+/+ germ cells, whereas an ~2-fold reduction in
CHD4 recruitment and only background levels of binding for senataxin similar to those obtained with negative control (nonspeciﬁc
(NS)) immunoglobulin G (IgG) were observed in the knockout. All data were plotted as the mean± s.d. Statistical analysis was
performed using the Student’s t-test, *Po0.05. Number of animals, n = 3. (d). Model depicting the coordinated action of
senataxin and CHD4 in silencing Timp1 during meiosis. Brieﬂy, under normal conditions R-loops form at the GC-rich region
upstream at the 5′-UTR of the Timp1 gene. Recruitment of senataxin and CHD4 occurs and leads to R-loop resolution, histone
deacetylation and silencing of Timp1 during meiosis.
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5'-UTR in the absence of senataxin, preventing
methylation of the region, and as CHD4 is not efﬁ-
ciently recruited, H3K9 acetylation is not removed,
thus leading to the aberrant expression of Timp1 during
MSCI in Setx−/−.
Discussion
We have previously shown that the disruption of
Setx in mice leads to a defect in meiotic recombination
and a failure in MSCI [20]. In this report, we have
provided greater mechanistic insight into the role of
senataxin in MSCI. Recent data suggest that meiotic
silencing involves a complex interplay between ATR
and other silencing effectors [47]. In that study, ATR
was shown to have multiple roles in silencing, including
the regulation of HORMA (Hop1, Rev7, Mad2)
domain protein HORMAD1/2 phosphorylation and
localization of ATRIP and TopBP1 to unsynapsed
axes of the XY chromosomes. ATR subsequently
transduces signaling at unsynapsed axes to the
surrounding chromatin with the assistance of MDC1
and phosphorylates H2AX (γH2AX), the epigenetic
event leading to gene inactivation. We have previously
shown that in the absence of senataxin, while ATR
localizes to the axial element of XY chromosomes,
it does not diffuse out into the surrounding
chromatin [20]. Nevertheless, under these conditions,
phosphorylation of H2AX (across the XY body)
appeared to be normal, suggesting that since ATR is
responsible for this phosphorylation, it was not
required to localize to the surrounding chromatin to
achieve this or that perhaps another PIKK was
involved in this phosphorylation. Royo et al. [47]
envisaged that when ATR translocates into chromatin
loops of unsynapsed regions, it leads to the induction
of repressive posttranslational modiﬁcations, such
as γH2AX, and causes irreversible gene silencing
over several megabases. Our results suggest that
phosphorylation of H2AX is not the rate-determining
step in gene silencing and that other modiﬁcations to
chromatin are also required.
As part of the response to DNA damage, ATRIP
forms a stoichiometric complex with ATR and by
binding directly to RPA, enables the accumulation of
ATR at the sites of DNA damage [48]. Taken together
with the involvement of a number of other regulatory
factors, this leads to ATR activation to coordinate cell
cycle checkpoints, replication fork stability and repli-
cation restart [49]. Not surprisingly, the mechanism of
ATR activation is conserved in meiosis where ATRIP
localizes with ATR, TopBP1 and RPA at unsynapsed
regions of meiotic chromosomes [50]. A recent report
revealed that ATRIP is SUMOylated in response to
agents that disrupt DNA replication and that ATRIP
mutants lacking SUMOylation sites failed to localize
to DNA damage sites and did not support efﬁcient
ATR activation [51, 52]. In promoting ATR activation,
SUMOylated ATRIP interacts with multiple proteins
including ATR, TopBP1, RPA and the MRN complex
not only through direct interaction but also through
interaction with SUMO proteins. Here we revealed a
marked reduction in SUMOylated proteins that
localize to the XY body in Setx−/− spermatocytes and
that senataxin, which localizes preferentially to the XY
body during the pachytene stage, is also SUMOylated.
It is possible that SUMOylated senataxin has a role in
DDR protein-mediatedMSCI. Indeed, we showed that
ATRIP localized predominantly to the axial elements
of the XY chromosomes but when senataxin was
disrupted there was a signiﬁcant reduction of its
association with the XY chromosomes. This might be
explained by lack of SUMOylation. It is also evident
from immunoblotting that in the absence of senataxin,
the protein levels of ATRIP present was markedly
reduced, providing an explanation for the reduced
ATRIP SUMOylation observed in Setx−/− spermato-
cytes. The lower levels of ATRIP and its markedly
reduced recruitment to the axial elements of XY
chromosomes are likely to contribute to the abnorm-
ality in ATR activity. Our data suggest that decreased
levels of NEK1 and its mislocalization in Setx−/−
pachytene cells accounts for the reduced levels of
ATRIP. Liu et al. [35] showed that even in undamaged
cells, NEK1 is required for maintaining levels of
ATRIP, the association between ATR and ATRIP,
and the basal kinase activity of ATR [35]. In this way,
NEK1 primes the ATR-ATRIP heterodimer for a
robust DNA damage response. Thus, the defect in
NEK1 and the consequent reduction in ATRIP protein
levels observed in Setx−/− pachytene spermatocytes
could account for the defective activation and signaling
through ATR leading to the failure of MSCI.
The great majority of SUMOylation staining was
localized to the XY body and in the absence of sena-
taxin, this is markedly reduced. As discussed above,
ATRIP was one of several SUMOylated proteins
associated with the XY body during meiosis. Others
include ATRX, which is a chromatin remodeling
protein shown recently to promote the incorporation of
histone variant H3.3 at particular transcribed genes to
facilitate transcriptional elongation through G-rich
sequences [53]. This is of interest as we showed that
senataxin is also SUMOylated and localizes to the XY
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body. The capacity of senataxin to resolve R-loops
[13, 14, 19, 20] and the propensity of GC-rich repeats to
form not only G-quadruplexes but also R-loops,
leading to abortive transcription [54], supports a
common goal for these two proteins in XY inactiva-
tion, ensuring that transcription is completed on the
XY chromosomes before entry into the diplotene stage.
Other SUMOylated proteins include DHX15, a
DEAH-box helicase that is part of the splicesosome
complex and contributes to the activation of signaling
pathways [55]; RUVB-like ATPase that functions in
chromatin decondensation [56] and YBOX transcrip-
tion factors. Clearly, all of these proteins have the
potential to be involved in remodeling chromatin on
the XY chromosomes to ensure the onset of gene
silencing or they could contribute to the re-emergence
of transcriptional activation at later stage of meiosis.
The marked deﬁciency in the recruitment of CHD4
to the XY body in Setx−/− pachytene cells and its role in
transcriptional regulation substantiates further a
central role for senataxin in gene silencing. CHD4 is a
core component of the NuRD corepressor complex
that remodels chromatin in a conformation refractory
to active transcription [57, 58]. We provided evidence
for the ﬁrst time that CHD4 interacts with senataxin
in situ on the XY body, which conﬁrms the interaction
between the two proteins demonstrated in proliferating
cells using afﬁnity chromatography, mass spectrometry
and immunoblotting [16]. CHD4 has also been shown
to interact with ATR [39]. In that study, ATR was
shown to be in a complex that included CHD4,
HDAC2 and other members of the NuRD complex,
suggesting that as part of the complex ATR would
have greater access to damaged DNA. CHD4 was
subsequently found to localize to sites of DNA damage
and cells depleted of this protein were hypersensitive to
DNA damaging agents, exhibited cell cycle abnorm-
alities and retained DNADSBs for extended periods of
time [59]. It was suggested that in CHD4-deﬁcient cells,
either the access of DNA repair proteins to the site
of damage is compromised or that the deﬁciency of
CHD4 leads to global alterations in higher-order
chromatin structure, rendering it more vulnerable to
accumulating DNA damage. Our data indicate that
CHD4 plays a similar role in remodeling chromatin to
allow access of silencing factors to asynapsed regions of
the XY chromosomes to turn off or prevent tran-
scription during meiosis. The defective recruitment of
CHD4 to the XY body in Setx−/− pachytene cells is
expected to result in more open chromatin since it
normally functions as a repressor of transcription
[37, 46]. CHD4, a part of the NuRD histone
deacetylase complex, is also involved in removing
acetylation marks from histones to convert open
transcriptionally active euchromatin into closed tran-
scriptionally inactive heterochromatin. Indeed, higher
levels of acetylated histones such as H3K9Ac and
H4K16Ac were observed on the XY body in Setx−/−.
Although H3K9Ac is present at low levels in the
early stages of prophase 1, it increases strongly by
midpachytene on autosomes but is excluded from XY
chromosomes which are initiatingMSCI [42]. H3K9Ac
strongly decorated the XY body in Setx−/− cells, which
is consistent with a failure of transcription repression
in Setx−/− pachytene cells. Furthermore, H3K4me1, a
marker of transcriptionally inactive heterochromatin,
was excluded from the XY body in Setx−/− spermato-
cytes, demonstrating the important role of senataxin in
coordinating CHD4 recruitment, histone modiﬁcation
and transcriptional silencing. This is in agreement
with the MSCI failure and abnormal expression of
X- and Y-linked genes observed previously [20].
Although H3K4me1 has generally been associated
with transcriptional activation, several reports have
been published discussing its role in silencing. Page
et al. [42] showed H3K4me1 localization to the XY
body during the pachytene stage, which prompted the
authors to suggest its involvement in transcriptional
silencing during MSCI. Additionally, Cheng et al. [60]
described its association with transcriptional silencing
in embryonic ﬁbroblasts, macrophages and human
embryonic stem cells. Thus, there exists evidence sug-
gesting both a role in transcriptional activation and
silencing for H3K4me1, which may depend on the cell
type investigated.
We have provided important mechanistic insight
into gene silencing of the XY chromosomes in meiosis
and the central role of senataxin in this process,
involving activation of ATR, recruitment of the
chromatin remodeler CHD4 and the ensuing post-
translational histone modiﬁcations necessary for
MSCI. These new data provided additional insight into
the sequence of events involved in MSCI (Figure 8) at
the pachytene stage. The initial step is BRCA1-
dependent recruitment of ATR and that of senataxin
as we have recently demonstrated [20]. In the absence
of senataxin, ATR, ATRIP and TopBP1 are all
retained on the axial element of the XY chromosomes.
Additionally, the protein levels of both ATRIP and
TopBP1 are reduced as well as their binding to the XY
chromosomes. Under these conditions, we did not
detect diffusion of ATR or its downstream substrates,
although normal levels of H2AX phosphorylation were
detected over the XY body. This suggests that another
Senataxin facilitates meiotic gene silencing
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PIKK distinct from ATR can carry out this phos-
phorylation. Although γH2AX is present, it does not
ensure that MSCI will occur, suggesting that it is not a
single determinant but is instead only one of several
required chromatin modiﬁcations to achieve gene
silencing. We provided further insight into this by
demonstrating the requirement for senataxin to recruit
CHD4 to the XY chromosomes and that these two
proteins interact at the level of the XY body. Speciﬁc
evidence of a concerted action between senataxin and
CHD4 on the XY chromosomes was demonstrated
at the X-linked Timp1 gene (Figure 7d). The higher
levels of histone acetylation modiﬁcations, which
were observed in Setx−/− spermatocytes, have been
previously associated with aberrant active gene
transcription for X- and Y-linked genes during
pachytene [20]. This is also in agreement with increased
levels of R-loop formation observed in Setx−/−
spermatocytes, which may also contribute to the failure
of MSCI and inhibition of meiosis [19, 20]. In sum-
mary, senataxin has been demonstrated to facilitate
transcription termination by resolving R-loops [13],
coordinate transcription with meiotic recombination
[20], act at the interface of transcription, DNA damage
response and RNA surveillance [5, 16] and protect
against DNA DSBs generated in transcription-coupled
DNA repair [61]. The ﬁndings in this report adds a new
level of complexity to senataxin’s function in meiosis
by demonstrating a direct role in modulating
chromatin remodeling and epigenetic gene silencing via
CHD4 and the ATR signaling pathway, and highlights
its pivotal role in coordinating gene regulation and the
DNA damage response.
Materials and Methods
Animal husbandry and genotyping
All animal experiments were approved by the QIMR Ber-
ghofer Medical Research Institute Animal Ethics Committee,
The University of Queensland. The mice were weaned at 21 days
postpartum and ear clipped for identiﬁcation. Genotyping was
carried out via polymerase chain reaction (PCR) on genomic
DNA isolated from tail tips as described in Becherel et al. [20].
Spermatocyte spreads
All spreads were made from testes collected from adult
35-day-old mice. Brieﬂy, testes were decapsulated, ﬁnely
Figure 8 Integrated role of senataxin in meiotic sex chromosome inactivation (MSCI). MSCI is initiated with breast cancer type 1
susceptibility protein (BRCA1) ﬁrst coating the axial element of the XY chromosomes during the pachytene stage. This is followed
by recruitment of senataxin and ataxia telangiectasia and Rad3-related protein (ATR)-interacting partner (ATR/ATRIP) where
both senataxin and ATRIP are present as SUMOylated proteins. Binding of TopBP1 activates ATR, which then disperses into the
XY chromatin domain where it functions to phosphorylate other proteins, which may include histone H2AX (γH2AX). This step is
senataxin-dependent. ATR diffusion into surrounding chromatin is not essential for H2AX phosphorylation as this occurs in the
absence of senataxin where ATR is conﬁned to the axial elements of XY chromosomes. Senataxin acts to resolve R-loops on XY
chromosomes and associates with CHD4, which is part of the nucleosome remodeling complex (NuRD), to assist in the
deacetylation of histones to downregulate active gene expression. The remodeling of chromatin for MSCI is dependent on
senataxin. In addition, monomethylation of H3K4 occurs, all of which gives rise to heterochromatin formation and XY silencing.
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chopped and rinsed in 1 ml of GIBCO serum-free DMEmedium
(Life Technologies, Carlsbad, CA, USA) containing 1×
Complete Protease Inhibitor (Roche, Basel, Switzerland).
Six microliters of GIBCO serum-free DME medium (Life
Technologies) was then added and tubes were allowed to stand
on ice for 5 min to allow large clumps and cellular debris to
settle. Six microliters of the remaining supernatant from each
sample was subsequently aliquoted into Eppendorf tubes, with
each tube containing 1 ml of suspension. Tubes were then
centrifuged for 5 min at 5 000 g to pellet the cell suspension. The
pellet was then resuspended in 0.1 M sucrose and applied onto
glass slides prewetted with 1% paraformaldehyde and 0.1%
Triton X-100 in phosphate-buffered saline (PBS). Cells
were ﬁxed on the glass slides and air-dried for 3 h at room
temperature. The slides were subsequently washed with 1:250
Kodak Photo-Flo 200 (Kodak Professional, Rochester, NY,
USA) in 1× PBS and air-dried for 1 h. Once dried, spreads were
stored at − 80 °C.
Immunoﬂuorescence
Spermatocyte spreads were blocked in 20% fetal calf serum,
2% bovine serum albumin (BSA), 0.2% Triton X-100 in 1× PBS
for 1 h at room temperature. Slides were incubated overnight at
4 °C in a humidiﬁed chamber with the following primary anti-
bodies diluted in blocking buffer: mouse monoclonal anti-SCP3
(Abcam, Cambridge, MA, USA; AB97672) at a 1:100 dilution,
rabbit anti-SCP3 (Novus Biologicals, Littleton, CO, USA;
NB300-230) at a 1:100 dilution, goat anti-ATR (Santa Cruz
Biotechnology, Dallas, TX, USA; SC-1887) at a 1:100 dilution,
rabbit anti-NEK1 (Bioss Inc., Woburn, MA, USA; BS-7814R)
at a 1:100 dilution, rabbit anti-ATRIP (Thermo Scientiﬁc,
Waltham, MA, USA; PA1-519) at a 1:100 dilution, mouse
monoclonal anti-CHK1 (Cell Signaling Technology, Danvers,
MA, USA; 2 360) at a 1:100 dilution, rabbit anti-CHD4 (Gen-
etex, Irvine, CA, USA; GTX124186), sheep anti-Setx (in-house)
at a 1:300 dilution, rabbit anti-TopBP1 (Abcam; AB2402) at a
1:100 dilution, rabbit anti SUMO-1 (Abcam; AB32058) at a
1:100 dilution, rabbit anti-SUMO-2/3 (Abcam; AB3742) at a
1:100 dilution, rabbit anti-phospho ATR (S428) (Cell Signaling
Technology; 2 853) at a 1:100 dilution, rabbit anti-phospho
RPA (S33) (Bethyl Laboratories Inc., Montgomery, TX, USA;
A300-246A) at a 1:100 dilution, rabbit anti-phospho CHK1
(S317) (Cell Signaling Technology; 2 344) at a 1:100 dilution,
rabbit anti-H3K4me1 (Abcam; AB8895) at a 1:100 dilution,
rabbit anti-H3K9Ac (Bioss Inc.; BS-3776A) at a 1:100 dilution,
and rabbit anti-H4K12Ac (Bioss Inc.; BS-3746R) at a 1:100
dilution. Slides were then rinsed three times with 1× PBS con-
taining 0.5% Triton X-100 for 5 min each at room temperature
on an orbital shaker. Slides were then incubated for 1 h at 37 °C
in a humidiﬁed chamber with the following Alexa-Dye-
conjugated secondary antibodies (Life Technologies) diluted
1:250 in blocking buffer: Alexa 488 chicken anti-mouse (A-
-21200), Alexa 594 donkey anti-rabbit (A-11032), Alexa 594
donkey anti-goat (A-11058) and Alexa 350 goat anti-mouse
(A-11045). Subsequently, slides were washed three times as
before and Hoechst 33342 (1:10 000) (Life Technologies) was
applied for 10 min to stain nuclei. Slides were ﬁnally washed two
times and glass coverslips were mounted for imaging. Images
were captured using a digital camera (AxioCam Mrm; Carl
Zeiss Microimaging Inc., Jena, Germany) attached to a ﬂuor-
escent microscope (Axioskop 2 mot plus; Carl Zeiss Micro-
imaging) equipped with the appropriate ﬁlters, and the
AxioVision 4.8 software (Carl Zeiss Microimaging Inc.). The
objective used was an EC Plan-Neoﬂuar 10x/0.3 (Carl Zeiss
Microimaging Inc.). Images were subsequently assembled in
Adobe Photoshop 5 (Adobe Systems, San Jose, CA, USA), and
contrast and brightness were adjusted on the whole image panel
at the same time. Fluorescence intensity was quantitated on at
least 50 individual cells per marker and condition using the
RAW images and NIH ImageJ software version 1.47 (NIH,
Bethesda, MD, USA). Statistical analysis was carried out using
Student’s t-test.
Proximity ligation assay
PLA (Duolink; Olink Bioscience, Uppsala, Sweden) was
performed according to the manufacturer's protocol with the
following primary antibodies: mouse monoclonal anti-SCP3
(Abcam; AB97672) at a 1:100 dilution, rabbit anti SUMO-1
(Abcam; AB32058) at a 1:100 dilution, rabbit anti-phospho
ATR (S428) (Cell Signaling Technology; 2 853) at a 1:100
dilution, sheep anti-Setx (in-house) at a 1:300 dilution, rabbit
anti-CHD4 (Abcam; AB72418), and rabbit anti-BRCA1 (with
courtesy of Prof. David Livingstone, Dana-Farber Cancer
Institute, Harvard Medical School, Boston, MA, USA) at a
1:300 dilution. Corresponding PLA PLUS and MINUS probes
were subsequently applied. Slide mounting and imaging was
performed as described above.
Immunoprecipitation of SUMOylated proteins from
Setx+/+ and Setx−/− testes
Testes of 35-day-old mice (ground with a pestle to disrupt
their structure) were lysed for 1 h at 4 °C on a rotating wheel
with 1 ml of lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mMNaCl,
2 mM EGTA, 2 mM EDTA, 25mM β-glycerophosphate, 0.1 mM
Na3VO4, 0.1 mM PMSF, 25mM NaF, 0.2% Triton X-100, 0.3%
NP-40 and 1× EDTA-free Complete Protease Inhibitor
(Roche) 25 μM NEM (Sigma-Aldrich, St Louis, MO, USA)).
Cellular debris was pelleted by centrifugation at 16 100 g at 4 °C
for 10 min, and protein concentration was determined using
Lowry Assay (Bio-Rad Laboratories Inc., Hercules, CA, USA).
Three micrograms of total cell extract were precleared with 20 μl
of protein A beads (50:50 slurry) (Merck Millipore, Billerica,
MA, USA) for 3 h at 4 °C on a rotating wheel. Extracts were
centrifuged for 5 min at 2 000 g, beads were removed and 10 μg
of anti-SUMO antibody (Abcam) was added to the extract.
Extracts and antibody were incubated overnight at 4 °C on a
rotating wheel to allow binding of the antibody to SUMOylated
protein. The next day, 40 μl of protein A beads (50:50 slurry)
(Merck Millipore) was added to the extract and incubated for
2 h at 4 °C on a rotating wheel. Extracts were centrifuged for
5 min at 2 000 g and the beads were removed. The immuno-
precipitate was subsequently washed three times with lysis buffer
and the beads were resuspended in SDS loading buffer con-
taining 2× DTT and separated via 4–12% SDS-PAGE using
Novex Tris-Glycine gels (Life Technologies) at 110 V for 1.5 h.
Once separated, gel was stained with G-250 Colloidal
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Coomassie (Life Technologies) overnight. Gel was subsequently
destained using Milli-Q water.
Tryptic digestion of SUMOylated proteins from mice
spermatocytes for LC-MS/MS
Bands were excised from gel using a sterile scalpel and were
left to destain (50% acetonitrile, 50% ammonium bicarbonate)
for 4 h. Trypsin (Promega, Madison, WI, USA) was added 1:20
by weight in 50mM ammonium bicarbonate until gel pieces
were covered and left to digest overnight. Subsequently, 100%
acetonitrile was added and tube was vortexed for 10min. Liquid
in the tube was then transferred into a fresh Eppendorf tube.
Fifty percent acetonitrile was added to the gel pieces and
vortexed again for 10min. Liquid was combined with the liquid
collected in the previous step. Tubes were spun in a Speedy-Vac
for 30min to dry liquid to ~ 5 μl. This volume was reconstituted
to 20 μl 0.1% triﬂuoroacetic acid (TFA) and applied to a C18
STAGE tip (Thermo Fisher Scientiﬁc, Waltham, MA, USA) by
pipetting up and down for ~ 10 times. Tips were then washed
with 10 μl of 0.1% TFA and peptides were eluted with 50%
acetonitrile intro a fresh Eppendorf tube. Eluant was frozen at
− 20 °C and shipped to DrMark E Graham (Children’s Medical
Research Institute, University of Sydney, NSW, Australia) for
liquid chromatography mass spectrometry analyses.
Liquid chromatography mass spectrometry identiﬁcation
of proteins immunoprecipitated from mice spermatocytes
Coomassie-stained protein bands from the anti-SUMO-1
immunoprecipitation SDS-PAGE gel were excised using a
sterile scalpel and were destained (50% acetonitrile, 50%
ammonium bicarbonate) for 4 h. Trypsin (Promega) was added
1:20 protein:trypsin by weight in 50mM ammonium bicarbonate
until gel pieces were covered and digested for 16 h. To extract
the tryptic peptides, the volume was increased by 50% with
acetonitrile, the tube was vortexed for 10min and the liquid was
then transferred into a fresh tube. An additional solution of 50%
acetonitrile in water was added to the gel pieces, the tube was
vortexed for 10min and the liquid was combined with the liquid
from the previous step. Tubes were spun in a Speedy-Vac for
30 min to dry liquid to ~ 5 μl. This volume was diluted to 20 μl
0.1% TFA and applied to a C18 STAGE tip (Thermo Fisher
Scientiﬁc) by pipetting up and down for ~ 10 times. Tips were
then washed with 10 μl of 0.1% TFA and peptides were eluted
with 50% acetonitrile into a tube for storage at − 20 °C. One-half
of each sample was analyzed by LC-MS/MS. A Dionex 3 000
Ultimate HPLC system was used (Dionex/Thermo Fisher
Scientiﬁc, Scoresby, VIC, Australia). Samples were loaded onto
a trap column (300 μm inside diameter, 1 mm long; Acclaim
PepMap100 C18, 5 μm, Thermo Fisher Scientiﬁc) for 5 min at
5 μl min− 1 with phase A (0.1% formic acid in water). The sample
was eluted through a 16 cm long, 75 μm inside diameter analy-
tical column (3 μm 120 Å Reprosil Pur C18-AQ; Dr Maisch
Gmbh, Ammerbuch-Entringen, Germany) at 250 nl min− 1. The
gradient was from 0 to 35% phase B (90% acetonitrile, 9.9%
water and 0.1% formic acid) in 65 min. Phase B was increased to
100% in 5min and held at 100% for 5 min. The column eluate
was sprayed into an LTQ Velos orbitrap mass spectrometer
(Thermo Fisher Scientiﬁc) through a 10 μm inside diameter
SilicaTip (New Objective) with 2.2 kV applied. Up to seven of
the most intense peptide precursor ions above a threshold of
5 000 counts were selected in the range m/z 300–1 500 for MS/
MS for 90min after the start of the gradient. Both MS and MS/
MS detection was in the orbitrap at a resolution of 30 000 and
7 500, respectively. Detailed parameters were as follows: isola-
tion width was 2 (m/z), normalized collision energy was 40,
activation time was 0.1 ms, +1 charge state ions were rejected,
ions within 100 ppm of previously selected ions were excluded
from MS/MS for 10 s, MS target was 1 000 000 counts for up to
50ms and MS/MS target was 50 000 for up to 300ms. All MS
raw data was submitted via Proteome Discoverer 1.3 (Thermo
Fisher Scientiﬁc) for database searching with Mascot 2.4
(Matrix Science, London, UK). The database was UniProtKB
(downloaded July 2013, Mus musculus, 16 673 entries). Pre-
cursor ion tolerance was 10 p.p.m. and fragment ion tolerance
was 0.05 Da. Variable modiﬁcations were deamidation (NQ)
and oxidation (M) and maximummissed trypsin cleavages was 3
(trypsin cleavage before proline was allowed). TheMascot result
ﬁles were imported to Scaffold 4.4.1 (Proteome Software, OR,
USA). Only proteins with at least two unique peptides were
considered. Protein false discovery rate was 0.1% and peptide
false discovery rate was 0.02%. Minimum protein probability of
identiﬁcation was 99% (Po0.01) and minimum peptide prob-
ability of identiﬁcation was 95% (Po0.05).
Immunoblotting for DDR proteins from Setx+/+ and Setx−/−
testes
Testes of 35-day-old mice (ground with a pestle to disrupt
their structure) were lysed for 1 h at 4 °C on a rotating wheel
with 1 ml of lysis buffer (50 mM Tris-HCl, pH 7.4, 150mMNaCl,
2 mM EGTA, 2mM EDTA, 25 mm β-glycerophosphate, 0.1 mM
Na3VO4, 0.1 mm PMSF, 25 mmNaF, 0.2% Triton X-100, 0.3%
NP-40 and 1× EDTA-free Complete Protease Inhibitor
(Roche)). Cellular debris was pelleted by centrifugation at
16 100 g at 4 °C for 10 min, and protein concentration was
determined using Lowry Assay (Bio-Rad). Thirty micrograms
of total cell extract were resuspended in SDS loading buffer
containing 2× DTT and separated via 4–12% SDS-PAGE using
Novex Tris-Glycine gels (Life Technologies) at 110 V for 1.5 h.
The proteins were then transferred onto a Hybond-C nitro-
cellulose membrane (Pall Life Sciences, NY, USA) using a high-
molecular-weight transfer buffer (100 mM Tris, 40 mM glycine,
0.05% SDS, 20% methanol) at 100 V for 1 h at 4 °C in a mini-
protean gel rig (Bio-Rad). Membranes were the blocked in 5%
skim milk in TBS/Tween-20 or 5% BSA/TBS/Tween-20 for 1 h
and immunoblotting was performed with the following primary
antibodies diluted 1:1 000 in 5% skim milk/TBS/Tween-20 or 5%
BSA/TBS/Tween-20 at 4 °C overnight: goat anti-ATR (Santa
Cruz Biotechnology; SC-1887), rabbit anti-NEK1 (Bioss Inc.,
BS-7814R), rabbit anti-ATRIP (Thermo Scientiﬁc; PA1-519),
mouse monoclonal anti-CHK1 (Cell Signaling Technology;
2 360), rabbit anti-CHD4 (Abcam; AB72418), sheep anti-Setx
(in-house), rabbit anti-TopBP1 (Abcam; AB2402), rabbit anti
SUMO-1 (Abcam; AB32058), rabbit anti-phospho ATR (S428)
(Cell Signaling Technology; 2 853), rabbit anti-glyceraldehyde
3-phosphate dehydrogenase (Genetex; GTX100118) and rabbit
anti-α tubulin (Genetex; GTX 112141). Membranes were
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subsequently washed thee times with TBS/Tween-20 for 5 min
each and incubated with the following secondary antibodies
conjugated with horseradish peroxidase (HRP) diluted 1:5 000
in 5% skim milk/TBS/Tween-20 or 5% BSA/TBS/Tween- 20 for
1 h at room temperature: HRP-conjugated donkey anti-sheep
(Merck Millipore; AP184P), HRP-conjugated donkey anti-
mouse (Merck Millipore; AP192P) and HRP-conjugated don-
key anti-rabbit (Merck Millipore; AP182P). Membranes were
then analyzed using the Western Lightning Plus Enhanced
Chemiluminescence (ECL) reagent (Perkin-Elmer, Waltham,
MA, USA).
Reverse transcription-PCR and gene expression analysis
Total RNA was isolated from 35-day-old mice testes
using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA)
according to the manufacturer's protocol. cDNA synthesis was
performed as described previously [20]. Primer pairs used for
reverse transcription-PCR gene expression analyses are detailed
in Supplementary Table S2.
ChIP assay
ChIP assays were performed as described previously [12].
Brieﬂy, crosslinking mix (11% formaldehyde, 100 mM NaCl,
0.5 mM EGTA, 50mM HEPES, pH 8.0, supplemented with
protease and phosphatase inhibitors) was added to testes of
35-day-old mice (ground with a pestle to disrupt their structure).
Crosslinking was quenched after 15 min with 1.25 M glycine and
lysed with ChIP lysis buffer (1% SDS, 10 mm EDTA, pH 8.0,
50 mM Tris-HCl, pH 8.0, supplemented with protease and
phosphatase inhibitors) for 30 min at 4 °C. DNA was sheared
by sonication and insoluble components were removed by
centrifugation. Two milligrams of protein was diluted to 600 ml
with dilution buffer (1% Triton X-100, 150 mM NaCl, 2 mM
EDTA, pH 8.0, 20 mM Tris-HCl, pH 8.0, supplemented with
protease and phosphatase inhibitors) and precleared with pro-
tein A-Sepharose/G-Sepharose beads (Amersham Biosciences,
Buckinghamshire, UK) and 4 μg of salmon sperm DNA.
Senataxin and CHD4 was immunoprecipitated separately using
2 μg of antibody overnight at 4 °C. DNA fragments were then
eluted in elution buffer (1% SDS, 100mM NaHCO3), puriﬁed
and analyzed by PCR. Primer pairs used for Timp1 are detailed
in Supplementary Table S2. PCR products were subsequently
quantitated using ImageJ 1.48v (NIH, Bethesda, MD, USA).
Results for each experiment were calculated relative to the input.
Error bars show the standard deviation and signiﬁcance was
determined using the Student's t-test.
RLFS prediction and DRIP assay
An RLFS was predicted (Dr Thidathip Wongsurawat,
personal communication) in the 5′-UTR region of Timp1. This
region was then used for DRIP analysis. Genomic DNA and
RNA extraction from mice testes were performed using the
DNeasy Blood and Tissue Kit (Qiagen) following the manu-
facturer's instructions. DRIP assay was then performed as
described previously [19]. Primer pairs for Timp1 are detailed in
Supplementary Table S2. PCR products were subsequently
quantitated using ImageJ 1.48v. Results for each experiment
were calculated relative to the input.
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